Chiral Phosphorus Ligands in Enantioselective Copper-Catalysed Conjugate Additions
FULL PAPER
H, ArH), 3.13Ϫ3.00 (m, 2 H, CyH), 2.83Ϫ2.78 (m, 1 H, CyH),
.57 (s, 3 H, SO CH ), 2.37 (s, 3 H, SO CH ), 2.20Ϫ2.18 (m, 1 H,
CyH), 1.49Ϫ1.18 (m, 4 H, CyH), 1.00Ϫ0.80 (m, 1 H, CyH), 1261, 1145, 1072 cm . [α]
0
1
130.7, 130.6, 130.3, 129.8, 129.3, 75.8, 73.8, 43.2, 41.6 ppm. 31P
NMR (162 MHz, C
): δ ϭ 108.2 ppm. IR (film): ν˜ ϭ 1640, 1329,
2
2
3
2
3
6 6
D
Ϫ1
25
D
ϭ Ϫ19.6 (c ϭ 1.00, THF). MS (FAB,
): δ ϭ glycerol): m/z (%) ϭ 475 (70), 375 (20), 353 (30), 289 (20), 274 (25),
30.8, 130.6, 130.4, 67.9, 65.9, 43.3, 37.4, 32.7, 29.4, 24.3, 24.1 ppm. 221 (35), 207 (50), 154 (90), 136 (100). HRMS (ESI): calcd. for
.55Ϫ0.45 (m, 1 H, CyH) ppm. 13C NMR (100 MHz, C
D
6 6
3
1
ϩ
P NMR (162 MHz, C
6
D
6
): δ ϭ 95.8 ppm. IR (film): ν˜ ϭ 1633,
C
22
H
23
N
2
NaO
4 2
PS : 497.0735 [M ϩ Na] ; found 497.0738.
Ϫ1
25
1
330, 1149, 1141, 1106, 1080, 1056 cm . [α]
D
ϭ Ϫ4.1 (c ϭ 1.00,
Ligand 5bdj: Method A, pale yellow powder (448 mg, 89%). 1
H
THF). MS (FAB, glycerol): m/z (%) ϭ 377 (100), 313 (45), 299 (20),
2
ϩ Na] ; found 399.0576.
NMR (200 MHz, C ): δ ϭ 7.57Ϫ6.85 (m, 15 H, ArH),
5.49Ϫ5.47 (m, 1 H, CHN), 5.13Ϫ5.09 (m, 1 H, CHN), 4.42Ϫ4.26
m, 2 H, CH Ph), 3.41 (br. s, 1 H, NH), 2.09 (s, 6 H, 2 ϫ SO CH
ppm. C NMR (50 MHz, C D ): δ ϭ 140.9, 139.7, 129.8, 129.4,
6 6
D
05 (30). HRMS (ESI): calcd. for C14
H
21
N
2
NaO
4
PS
2
: 399.0578 [M
ϩ
(
2
2
3
)
1
13
Ligand 5adj: Method A, yellow powder (365 mg, 90%). H NMR
6
6
3
1
(
400 MHz, C
H, CH ), 2.36 (s, 6 H, 2 ϫ SO
.30Ϫ1.26 (m, 2 H, CyH), 1.05Ϫ0.60 (m, 6 H, CyH) ppm.
NMR (100 MHz, C ): δ ϭ 129.1, 129.0, 128.6, 66.5, 43.1, 29.5,
3.6 ppm. 31P NMR (162 MHz, C
D ): δ ϭ 134.9 ppm. IR (film): found 504.1197; calcd. for C H N NaO PS : 526.1000 [M ϩ
6 6
23 26 3 4 2
6
D
6
): δ ϭ 7.14Ϫ7.00 (m, 5 H, ArH), 3.15Ϫ3.11 (m, 2 128.7, 127.9, 127.6, 70.7, 70.4, 47.9, 42.7, 42.0 ppm. P NMR
2
2
CH ), 2.18Ϫ2.10 (m, 2 H, CyH), (162 MHz, C D ): δ ϭ 101.4 ppm. IR (film): ν˜ ϭ 3371, 1635, 1336,
3
6
6
1
3
Ϫ1
25
1
C
1316, 1163, 1145, 1088, 1073 cm . [α]D ϭ Ϫ12.8 (c ϭ 1.00, THF).
ϩ
6
D
6
HRMS (ESI): calcd. for C H N O PS : 504.1181 [M ϩ H] ;
2
3
27
3
4
2
2
Ϫ1
25
ϩ
ν˜ ϭ 3392, 1653, 1159 cm . [α]
ϭ Ϫ3.4 (c ϭ 1.02, THF). HRMS
Na] ; found 526.1024.
D
(
ESI): calcd. for fragment C H N O S : 270.0708; found 270.0710.
8 18 2 4 2
Ligand 5ceh: Method C, pale orange powder (354 mg, 98%). 1
NMR (200 MHz, C D ): δ ϭ 7.60Ϫ5.75 (m, 20 H, ArH),
6 6
3.78Ϫ3.57 (m, 2 H, 2 ϫ CH), 1.97 (s, 3 H, ArCH ), 1.90 (s, 3 H,
3
H
Ligand 5beh: Method C, brownish powder (260 mg, 80%). 1
NMR (400 MHz, C ): δ ϭ 7.87 (d, J ϭ 8 Hz, 2 H, ArH), 7.85
d, J ϭ 8 Hz, 2 H, ArH), 7.26Ϫ7.14 (m, 6 H, ArH), 6.71Ϫ6.63 (m, ArCH ), 1.52Ϫ1.46 (m, 12 H, 4 ϫ CH ) ppm. 13C NMR (50 MHz,
H
6
D
6
(
4
5
2
3
3
H, ArH), 6.46Ϫ6.39 (m, 3 H, ArH), 6.28Ϫ6.24 (m, 1 H, ArH),
6 6
C D ): δ ϭ 141.9, 141.8, 136.9, 133.3, 132.9, 131.9, 130.9, 130.1,
.63 (dd, J ϭ 5.9 Hz, 1.18 Hz, 1 H, CHN), 4.95 (dd, J ϭ 5.8 Hz, 129.7, 128.8, 126.8, 127.4, 51.4, 25.0, 23.4, 21.2, 20.1. 31P NMR
.4 Hz, 1 H, CHN), 3.93Ϫ3.79 (m, 2 H, 2 ϫ CH), 1.91 (s, 3 H, (162 MHz, C D ): δ ϭ 129.4 ppm. IR (film): ν˜ ϭ 1632, 1596, 1342,
6
6
ArCH
3
), 1.87 (s, 3 H, ArCH
3
), 1.69Ϫ1.61 (m, 12 H, 4 ϫ CH
3
)
1261, 1201, 1161, 1089, 1027 cmϪ1. [α] 2D 5 ϭ Ϫ9.0 (c ϭ 1.00, THF).
ppm. 13C NMR (100 MHz, C
D ): δ ϭ 143.2, 141.8, 137.8, 129.7, HRMS (ESI): calcd. for C H N NaO PS : 744.2096 [M ϩ Na] ;
6 6
40 40 3 4 2
31
ϩ
1
28.8, 128.6, 127.3, 72.5, 70.9, 63.4, 48.8, 47.5, 21.1, 19.3 ppm.
P
found 744.2112.
NMR (162 MHz, C
6
D
6
): δ ϭ 110.1 ppm. IR (film): ν˜ ϭ 1599, 1559,
1
Ϫ1
25
Ligand 5ceo: Method C, yellow powder (342 mg, 98%). H NMR
1
(
6
348, 1157, 1089 cm . [α]
ESI): calcd. for C34
50.2250; calcd. for C34
found 672.2102.
D
ϭ ϩ35.0 (c ϭ 1.00, THF). HRMS
ϩ
6 6
(200 MHz, C D ): δ ϭ 8.42Ϫ8.38 (m, 2 H, ArH), 7.79Ϫ7.48 (m, 7
H, ArH), 7.30Ϫ6.92 (m, 10 H, ArH), 6.69Ϫ6.55 (m, 4 H, ArH),
H
41
N
3
O
4
PS
2
: 650.2276 [M ϩ H] ; found
ϩ
40 3 4 2
H N NaO PS : 672.2096 [M ϩ Na] ;
6
1
1
1
1
1
.12 (d, J ϭ 8.2 Hz, 1 H, ArH), 5.96 (d, J ϭ 8.2 Hz, 1 H, ArH),
1
3
.96 (s, 6 H, 2 ϫ ArCH
44.1, 137.3, 135.1, 133.0, 131.4, 131.3, 130.2, 128.7, 127.8, 127.5,
3 6 6
) ppm. C NMR (50 MHz, C D ): δ ϭ
Ligand 5beo: Method C, brownish powder (232 mg, 74%). 1
NMR (400 MHz, C ): δ ϭ 8.46 (t, J ϭ 7.3 Hz, 2 H, ArH), 8.04
H
D
6
31
6
25.7, 125.2, 120.0, 21.5 ppm. P NMR (162 MHz, C
6
D ): δ ϭ
6
(
(
d, J ϭ 8.2 Hz, 2 H, ArH), 7.71Ϫ7.67 (m, 2 H, ArH), 7.26Ϫ7.04
m, 6 H, ArH), 6.92Ϫ6.78 (m, 5 H, ArH), 6.64Ϫ6.49 (m, 4 H,
31.7 ppm. IR (film): ν˜ ϭ 1633, 1593, 1349, 1302, 1261, 1211, 1158,
Ϫ1
25
088 cm . [α]
D
ϭ Ϫ1.48 (c ϭ 1.01, THF). MS (FAB, glycerol):
ArH), 6.24Ϫ6.22 (m, 2 H, ArH), 5.42 (d, J ϭ 7.0 Hz, 1 H, CHN),
.23 (d, J ϭ 7.0 Hz, 1 H, CHN), 1.99 (s, 3 H, ArCH ), 1.94 (s, 3
H, ArCH ): δ ϭ 143.9, 142.7,
) ppm. 13C NMR (100 MHz, C
42.0, 139.7, 138.9, 137.1, 135.7, 130.7, 130.5, 130.4, 130.2, 139.4,
m/z (%) ϭ 698 (30), 599 (90), 438 (90), 282 (95), 267 (65), 177
100), 152 (80), 136 (45), 107 (30), 89 (60). HRMS (ESI): calcd. for
5
3
(
3
6
D
6
C
H
31
N
2
NaO
PS
2
: 721.1361 [M ϩ Na] ; found 721.1378.
ϩ
40
4
1
1
1
29.3, 129.2, 129.1, 127.0, 77.2, 74.3, 18.6, 17.2 ppm. 3 P NMR
): δ ϭ 107.6 ppm. IR (film): ν˜ ϭ 1348, 1156, 1088
ϭ ϩ29.5 (c ϭ 1.00, THF). HRMS (ESI): calcd. for
1
Ligand 5cdi: Method A, yellow powder (503 mg, 98%). H NMR
(
200 MHz, C
6 6
D ): δ ϭ 8.25Ϫ6.85 (m, 12 H, ArH), 2.64 (s, 3 H,
(
6 6
162 MHz, C D
Ϫ1
25
SO CH ), 2.61 (s, 3 H, SO CH ), 2.31 (s, 3 H, CH ), 2.26 (s, 3 H,
cm . [α]
D
2
3
2
3
3
1
3
ϩ
3 6 6
CH ) ppm. C NMR (50 MHz, C D ): δ ϭ 135.0, 131.4, 131.1,
28.7, 125.8, 125.2, 120.1, 40.3, 34.2 ppm. P NMR (162 MHz,
C
34
H
31
N
2
NaO
4
PS
2
: 649.1361 [M ϩ Na] ; found 649.1342.
3
1
1
Ligand 5bdi: Method A, pale yellow powder (415 mg, 94%). 1
H
6 6
C D
1
): δ ϭ 125.5 ppm. IR (film): ν˜ ϭ 1620, 1590, 1261, 1159, 1076,
NMR (200 MHz, C ): δ ϭ 7.58Ϫ7.53 (m, 2 H, ArH), 7.17Ϫ6.94
m, 8 H, ArH), 5.48 (d, J ϭ 5.8 Hz, 1 H, CHN), 5.09Ϫ5.05 (m, 1
H, CHN), 2.79 (s, 3 H, NCH ), 2.75 (s, 3 H, NCH ), 2.14 (s, 3 H,
SO CH ), 2.01 (s, 3 H, SO CH
) ppm. 13C NMR (50 MHz, C
δ ϭ 138.4, 137.8, 129.5, 129.3, 129.2, 129.1, 129.0, 128.9, 70.8, 69.1, (200 MHz, C
6
D
6
Ϫ1
25
021 cm . [α]
D
ϭ ϩ24.73 (c ϭ 1.01, THF). HRMS (ESI): calcd.
(
ϩ
for C24 NaO
H
24
N
3
4
PS
2
: 536.5607 [M ϩ Na] ; found 536.5671.
3
3
1
D
6
): Ligand 5cdo: Method C, golden powder (270 mg, 99%). H NMR
2
3
2
3
6
6
D
6
): δ ϭ 8.28Ϫ8.01 (m, 2 H, ArH), 7.83Ϫ7.52 (m, 5
H, ArH), 7.36Ϫ6.82 (m, 10 H, ArH), 1.91 (s, 3 H, SO CH ), 1.59
): δ ϭ 133.8,
133.6, 133.3, 132.9, 132.1, 131.9, 131.3, 130.2, 128.9, 128.7, 128.5,
4
1
2.6, 42.3, 37.8, 37.5 ppm. 31P NMR (162 MHz, C
12.5 ppm. IR (film): ν˜ ϭ 1602, 1146, 1079 cm . [α]
6
Ϫ1
D
6
): δ ϭ 116.9,
2
3
25
13
ϭ Ϫ3.8
2 3 6 6
(s, 3 H, SO CH ) ppm. C NMR (50 MHz, C D
D
(c ϭ 0.99, THF). MS (FAB, glycerol): m/z (%) ϭ 441 (100). HRMS
3
1
(
3
ESI): calcd. for fragment C16
91.0765.
H
20
N
2
NaO
4
S
2
: 391.0762; found
127.1, 126.9, 126.1, 125.5, 120.4, 43.1, 41.0, 40.0 ppm. P NMR
(162 MHz, C
): δ ϭ 129.8 ppm. IR (film): ν˜ ϭ 1632, 1590, 1345,
6 6
D
Ϫ1
25
1
153, 1093 cm . [α]
calcd. for C28
69.0724.
D
ϭ ϩ33.7 (c ϭ 1.00, THF). HRMS (ESI):
1
Ligand 5bdo: Method C, white powder (211 mg, 89%). H NMR
ϩ
H
23
N
2
NaO
4
PS
2
: 569.0735 [M ϩ Na] ; found
(200 MHz, C
6 6
D ): δ ϭ 8.38Ϫ8.28 (m, 1 H, ArH), 7.36Ϫ7.24 (m, 8
5
H, ArH), 7.22Ϫ7.15 (m, 2 H, ArH), 7.11Ϫ7.07 (m, 1 H, ArH),
1
7.05Ϫ6.86 (m, 3 H, ArH), 5.64 (d, J ϭ 7.2 Hz, 1 H, CHN), 5.52 Ligand 5cdj: Method A, yellow powder (489 mg, 85%). H NMR
(
SO
2 3 6 6
d, J ϭ 7.2 Hz, 1 H, CHN), 2.29 (s, 3 H, SO CH ), 2.05 (s, 3 H, (200 MHz, C D ): δ ϭ 8.10Ϫ6.80 (m, 17 H, ArH), 4.39 (s, 2 H,
CH
3
) ppm. 13C NMR (50 MHz, C
6
D
6
): δ ϭ 142.2, 141.3, 138.4,
CH
2
Ph), 2.15 (s, 3 H, SO
2
CH
3
), 2.10 (s, 3 H, SO
2
CH
3
) ppm.
13
C
2
Eur. J. Org. Chem. 2004, 3557Ϫ3565
www.eurjoc.org
2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
3563